ArticleFrontiers in oncology2022

Non-apoptotic activity of the mitochondrial protein SMAC/Diablo in lung cancer: Novel target to disrupt survival, inflammation, and immunosuppression.

Swaroop Kumar Pandey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.